Aventa, which is owned by Agostini Limited, is said to be monopolising the pharmaceutical market in the country, creating a situation of anti-competitive behaviour.

The accusation comes from the Private Pharmacy Retail Business Association, which has raised the matter with the Fair Trading Commission.

But the Commission's response has come under serious scrutiny at the Public Administration and Appropriations Committee of Parliament.

Alicia Boucher has more in this report.